Senior insider sale
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$941.5K
25.11K shares
What this filing means
KNIGHT JEFF E. plans to sell 25.11K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $941.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001628280-26-017948
Officer· Chief Operating Officer
Since Aug 2021
25.11K
Shares to sell
$941.5K
Approx. market value
25.11K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
3/15/2026
25.11KTotal acquired25.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2026 | Restricted Stock Unit Vesting Compensation | 25.11K | — |
| Total | 25.11K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
25.11K
Market value
$941.5K
3/16/2026
Total
Units
25.11K
Value
$941.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 25.11K | $941.5K | Nasdaq | Planned |
| Total | 25.11K | $941.5K | ||